ONTOLOGY REPORT - ANNOTATIONS
| Term: | dipyridamole |
|
| Accession: | CHEBI:4653
|
browse the term
|
| Definition: | A pyrimidopyrimidine that has formula C24H40N8O4. |
| Synonyms: | exact_synonym: | 2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol |
| | related_synonym: | C24H40N8O4; Cardoxin; Cleridium 150; Curantyl; Dipyridamine; Dipyudamine; Dypyridamol; InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2; InChIKey=IZEKFCXSFNUWAM-UHFFFAOYSA-N; OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO; Persantin; dipiridamol; dipyridamolum |
| | xref_casrn: | 58-32-2 |
| | xref: | Beilstein:0068373 "Beilstein Registry Number"; ChEMBL:186042 "ChEMBL COMPOUND"; ChemIDplus:58-32-2 "CAS Registry Number"; DrugBank:DB00975 "DrugBank"; KEGG DRUG:D00302 "KEGG DRUG" |
| | xref_mesh: | MESH:D004176 |
| | xref: | Patent:GB807826 "Patent"; Patent:US3031450 "Patent"; Wikipedia:Dipyridamole "Wikipedia" |
|
|
dipyridamole
|
| G |
ABCC4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
decreases activity |
EXP |
13 |
95,672,083 |
95,953,687 |
RGD:6480464 |
CTD |
| G |
ABCC4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
multiple interactions |
EXP |
13 |
95,672,083 |
95,953,687 |
RGD:6480464 |
CTD |
| G |
ADORA3 |
adenosine A3 receptor |
|
increases expression |
ISO |
1 |
112,025,970 |
112,106,597 |
RGD:6480464 |
CTD |
| G |
APOE |
apolipoprotein E |
|
multiple interactions |
EXP |
19 |
45,409,039 |
45,412,650 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
decreases secretion |
EXP |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
EXP |
2 |
201,980,877 |
202,037,411 |
RGD:6480464 |
CTD |
| G |
CLDN5 |
claudin 5 |
|
increases expression |
ISO |
22 |
19,510,547 |
19,512,860 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL3A1 |
collagen, type III, alpha 1 |
|
multiple interactions |
EXP |
2 |
189,839,099 |
189,877,472 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
DIABLO |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
EXP |
12 |
122,692,209 |
122,712,068 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
increases phosphorylation |
ISO |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
increases phosphorylation |
ISO |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
FADD |
Fas (TNFRSF6)-associated via death domain |
|
increases expression |
EXP |
11 |
70,049,269 |
70,053,508 |
RGD:6480464 |
CTD |
| G |
FADD |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
EXP |
11 |
70,049,269 |
70,053,508 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
8 |
42,128,820 |
42,190,171 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
decreases expression |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
INSR |
insulin receptor |
|
multiple interactions |
EXP |
19 |
7,112,266 |
7,294,011 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
multiple interactions |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
increases expression |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
increases activity |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NPPB |
natriuretic peptide B |
|
increases expression |
EXP |
1 |
11,917,521 |
11,918,992 |
RGD:6480464 |
CTD |
| G |
ORM1 |
orosomucoid 1 |
|
multiple interactions |
EXP |
9 |
117,085,303 |
117,088,759 |
RGD:6480464 |
CTD |
| G |
ORM1 |
orosomucoid 1 |
|
affects binding |
EXP |
9 |
117,085,303 |
117,088,759 |
RGD:6480464 |
CTD |
| G |
ORM2 |
orosomucoid 2 |
|
multiple interactions |
EXP |
9 |
117,092,069 |
117,095,536 |
RGD:6480464 |
CTD |
| G |
PDE10A |
phosphodiesterase 10A |
|
multiple interactions |
EXP |
6 |
165,740,776 |
166,075,588 |
RGD:6480464 |
CTD |
| G |
PDE11A |
phosphodiesterase 11A |
|
multiple interactions |
EXP |
2 |
178,487,977 |
178,973,066 |
RGD:6480464 |
CTD |
| G |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
|
increases expression |
ISO |
1 |
66,258,193 |
66,840,262 |
RGD:6480464 |
CTD |
| G |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
|
decreases activity |
EXP |
4 |
120,415,550 |
120,549,981 |
RGD:6480464 |
CTD |
| G |
PDE7A |
phosphodiesterase 7A |
|
multiple interactions |
EXP |
8 |
66,626,569 |
66,753,969 |
RGD:6480464 |
CTD |
| G |
PDE7B |
phosphodiesterase 7B |
|
multiple interactions |
EXP |
6 |
136,172,834 |
136,516,709 |
RGD:6480464 |
CTD |
| G |
PDE7B |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
6 |
136,172,834 |
136,516,709 |
RGD:6480464 |
CTD |
| G |
PDE7B |
phosphodiesterase 7B |
|
multiple interactions |
EXP |
6 |
136,172,834 |
136,516,709 |
RGD:6480464 |
CTD |
| G |
PDE7B |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
6 |
136,172,834 |
136,516,709 |
RGD:6480464 |
CTD |
| G |
PDE8A |
phosphodiesterase 8A |
|
multiple interactions |
EXP |
15 |
85,523,744 |
85,682,376 |
RGD:6480464 |
CTD |
| G |
PDE8A |
phosphodiesterase 8A |
|
multiple interactions |
ISO |
15 |
85,523,744 |
85,682,376 |
RGD:6480464 |
CTD |
| G |
PDE8B |
phosphodiesterase 8B |
|
multiple interactions |
EXP |
5 |
76,506,706 |
76,724,081 |
RGD:6480464 |
CTD |
| G |
PDE8B |
phosphodiesterase 8B |
|
multiple interactions |
EXP |
5 |
76,506,706 |
76,724,081 |
RGD:6480464 |
CTD |
| G |
PLAT |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
8 |
42,032,236 |
42,065,194 |
RGD:6480464 |
CTD |
| G |
PLAT |
plasminogen activator, tissue |
|
increases secretion |
EXP |
8 |
42,032,236 |
42,065,194 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
RCAN1 |
regulator of calcineurin 1 |
|
affects binding |
EXP |
21 |
35,888,782 |
35,987,382 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
EXP |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
EXP |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases activity |
EXP |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
EXP |
6 |
44,187,242 |
44,201,888 |
RGD:6480464 |
CTD |
| G |
SLC29A2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
multiple interactions |
EXP |
11 |
66,129,992 |
66,139,291 |
RGD:6480464 |
CTD |
| G |
SLC29A2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
multiple interactions |
ISO |
11 |
66,129,992 |
66,139,291 |
RGD:6480464 |
CTD |
| G |
SLC4A1 |
solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) |
|
multiple interactions |
EXP |
17 |
42,325,758 |
42,345,502 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TH |
tyrosine hydroxylase |
|
decreases expression |
ISO |
11 |
2,185,159 |
2,193,035 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
decreases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
multiple interactions |
ISO |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
1 |
101,185,196 |
101,204,601 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases secretion |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
Term paths to the root
|